GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited scores highest on Anchor (93) and lowest on Price (24). Its PosiPenta is 61.76 out of 100, better than most similar companies.
On the Penta Grid this week, GlaxoSmithKline Pharmaceuticals Limited is Grid #21 of 168 in the Healthcare sector in India, and Grid #293 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals Limited | 61.76 | 24 | 50 | 50 | 92 | 93 |
| Ajanta Pharma Limited | 65.67 | 35 | 56 | 75 | 80 | 82 |
| Anthem Biosciences Limited | 55.68 | 11 | 47 | 63 | 82 | 76 |
| Gland Pharma Limited | 65.08 | 46 | 60 | 98 | 60 | 61 |
| Emcure Pharmaceuticals Limited | 58.76 | 43 | 63 | 70 | 60 | 59 |
| Ipca Laboratories Limited | 63.54 | 46 | 55 | 84 | 65 | 69 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 39.09 |
| P/B ratio | 18.41 |
EEarnings
| Trailing EPS | ₹63.05 |
| Forward EPS | ₹79.17 |
NNitro
| Price | 2464.40 |
| 52-week high | 3120.70 |
| 52-week low | 2088.10 |
| Fall from 52-week high | 21.0% |
TTorque
| Return on equity (ROE) (calculated) | 47.11% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.07 |
| Market cap | ₹41,748 Cr |
| Promoter holding | 75.00% |
| Dividend yield | 2.28% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is GlaxoSmithKline Pharmaceuticals Limited's PosiPenta score?
GlaxoSmithKline Pharmaceuticals Limited's PosiPenta is 61.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does GlaxoSmithKline Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, GlaxoSmithKline Pharmaceuticals Limited is Grid #21 of 168 in the Healthcare sector in India, and Grid #293 of 2,356 in India.
Which PosiPenta pillar is strongest for GlaxoSmithKline Pharmaceuticals Limited?
Anchor (stability and dividends), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for GlaxoSmithKline Pharmaceuticals Limited?
Price (valuation), with a score of 24 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.